Main Management Fund Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-598,200	Closed	-$55.5M	–	7
2024 Q2	$55.5M	Buy	598,200 +45,700	+8%	+$4.1M	9.99%	4
2024 Q1	$52.4M	Buy	552,500 +81,000	+17%	+$7.52M	10.66%	3
2023 Q4	$42.1M	Buy	471,500 +190,500	+68%	+$14.1M	11.79%	2
2023 Q3	$20.5M	Buy	281,000 +37,500	+15%	+$3M	5.97%	7
2023 Q2	$20.3M	Buy	243,500 +45,200	+23%	+$3.78M	6.53%	7
2023 Q1	$15.1M	Buy	198,300 +28,300	+17%	+$2.35M	6.59%	7
2022 Q4	$14.1M	Buy	170,000 +10,600	+7%	+$858K	8.9%	7
2022 Q3	$12.6M	Buy	159,400 +10,500	+7%	+$885K	9.08%	5
2022 Q2	$11.1M	Buy	148,900 +83,500	+128%	+$6.27M	7.82%	5
2022 Q1	$5.88M	Buy	+65,400	New	+$6.04M	3.8%	7